Partner Therapeutics, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$26.1M
Doctors Paid
562
Transactions
1,807
2024 Total
$481,918
Payment Breakdown by Category
Research$23.5M (90.4%)
Consulting$2.1M (8.1%)
Travel$25,268 (0.1%)
Food & Beverage$22,637 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $23.5M | 631 | 90.4% |
| Consulting Fee | $2.1M | 276 | 8.1% |
| Grant | $246,304 | 4 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $111,118 | 57 | 0.4% |
| Travel and Lodging | $25,268 | 78 | 0.1% |
| Food and Beverage | $22,637 | 748 | 0.1% |
| Education | $4,519 | 11 | 0.0% |
| Honoraria | $3,000 | 2 | 0.0% |
Payments by Type
Research
$23.5M
631 transactions
General
$2.5M
1,176 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| SCOPE | $16.3M | 0 | 483 |
| iLEUK Pulm | $3.0M | 0 | 49 |
| Parkinsons II | $1.2M | 0 | 23 |
| UNE Parkinsons | $531,665 | 0 | 11 |
| MELANOMA II | $402,734 | 0 | 1 |
| UCSF Biliary | $291,533 | 0 | 2 |
| Safety, Tolerability and Biomarker Assessments of Leukine During Extended Time Treatment for PD | $267,251 | 0 | 1 |
| GRACE | $222,360 | 0 | 1 |
| Sargarmostim Retrospective Chart Review | $197,000 | 0 | 4 |
| Haplo Transplant | $125,008 | 0 | 1 |
| CART-T Preclinical | $117,003 | 0 | 1 |
| PTI-001-005a | $107,075 | 0 | 1 |
| Immunologic Assessment of cholangiosarcoma patients undergoing immunotherpay with GMCSF and pembrolizumab | $100,000 | 0 | 1 |
| NS Haplo Transplant | $79,887 | 0 | 5 |
| iLEUKPULM | $79,038 | 0 | 7 |
| iLeukPulm | $69,902 | 0 | 1 |
| PAD | $68,968 | 0 | 4 |
| GM-CF in Peripheral Arterial Disease GPAD Study III | $65,988 | 0 | 1 |
| PAD ISR | $60,000 | 0 | 1 |
| Haplo | $46,208 | 0 | 5 |
| Melanoma II | $45,198 | 0 | 3 |
| Phase II Trial of GM-CSF Plus Maintenance Pembrolizumab +/- Pemetrexed After Completion of First Line Chemo-Immunotherapy in Advanced Non-Small Cell Lung Cancer Patients with PDL-1 | $33,604 | 0 | 2 |
| Halpo ISR Study Northside Hospital | $27,761 | 0 | 2 |
| G-PAD | $26,122 | 0 | 1 |
| NSCLC ISR | $23,490 | 0 | 2 |
| ILeukPulm | $22,271 | 0 | 16 |
| Phase II GM-CSF + Maintenance Pembrolizumab +/- Pemetrexed After Completion of First Line Chemo-Immunotherapy in Advanced NSCLC Pts w PDL-1 | $1,542 | 0 | 1 |
| SALIENT | $1,000 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Hematology & Oncology | $1.4M | 220 | $6,587 |
| Internal Medicine | $191,184 | 63 | $3,035 |
| Neurology | $141,390 | 10 | $14,139 |
| Medical Oncology | $130,282 | 91 | $1,432 |
| Critical Care Medicine | $55,157 | 10 | $5,516 |
| Nephrology | $42,255 | 1 | $42,255 |
| Infectious Disease | $32,875 | 11 | $2,989 |
| Specialist | $21,788 | 25 | $871.53 |
| Pediatric Hematology-Oncology | $21,594 | 8 | $2,699 |
| Hematology | $15,237 | 38 | $400.96 |
| Rheumatology | $12,000 | 1 | $12,000 |
| Pediatrics | $8,409 | 3 | $2,803 |
| Contractor | $5,800 | 1 | $5,800 |
| Gastroenterology | $5,381 | 3 | $1,794 |
| Student in an Organized Health Care Education/Training Program | $4,941 | 8 | $617.66 |
| Pediatric Infectious Diseases | $4,071 | 3 | $1,357 |
| Pediatric Critical Care Medicine | $3,633 | 1 | $3,633 |
| Pulmonary Disease | $3,311 | 6 | $551.83 |
| Foot & Ankle Surgery | $3,100 | 1 | $3,100 |
| Ophthalmology | $2,500 | 1 | $2,500 |
| Anatomic Pathology & Clinical Pathology | $2,391 | 2 | $1,196 |
| Obstetrics & Gynecology | $1,896 | 4 | $473.89 |
| Adolescent Medicine | $1,357 | 1 | $1,357 |
| Radiation Oncology | $1,324 | 13 | $101.83 |
| Podiatrist | $695.09 | 2 | $347.55 |
| Urology | $355.34 | 2 | $177.67 |
| Family | $187.50 | 1 | $187.50 |
| General Practice | $144.90 | 3 | $48.30 |
| Legal Medicine | $84.74 | 1 | $84.74 |
| Surgery | $65.25 | 4 | $16.31 |
| Plastic Surgery | $61.76 | 4 | $15.44 |
| Dermatology | $61.52 | 2 | $30.76 |
| Hospitalist | $52.11 | 3 | $17.37 |
| Surgical Oncology | $36.22 | 2 | $18.11 |
| Gynecologic Oncology | $24.59 | 1 | $24.59 |
| Diagnostic Radiology | $16.28 | 1 | $16.28 |
| Psychiatry | $13.91 | 1 | $13.91 |
| Emergency Medicine | $13.87 | 1 | $13.87 |
| Family Medicine | $13.08 | 1 | $13.08 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Hillard Lazarus, Md, MD | Hematology & Oncology | Cleveland, OH | $1.3M | $0 |
| Nicholas Dainiak, M.d, M.D | Internal Medicine | Bridgeport, CT | $139,125 | $0 |
| Dr. Santosh Kesari, Md Phd, MD PHD | Neurology | Santa Monica, CA | $86,060 | $0 |
| Rekha Abichandani, M.d, M.D | Nephrology | Cambridge, MA | $42,255 | $0 |
| Dr. Eric Siemers, M.d, M.D | Neurology | Indianapolis, IN | $36,455 | $0 |
| Dr. Robert Gale | Medical Oncology | Los Angeles, CA | $33,961 | $0 |
| Tisha Wang, Md, MD | Critical Care Medicine | Los Angeles, CA | $26,640 | $0 |
| Ahmad Tarhini, Md, MD | Hematology & Oncology | Pittsburgh, PA | $18,302 | $0 |
| James Armitage, Md, MD | Hematology & Oncology | Omaha, NE | $17,419 | $0 |
| Elinor Lee, Md, MD | Internal Medicine | Los Angeles, CA | $16,357 | $0 |
| Bruce Trapnell, M.d, M.D | Internal Medicine | Cincinnati, OH | $16,019 | $0 |
| Rana Hejal, Md, MD | Critical Care Medicine | Cleveland, OH | $14,671 | $0 |
| Nelson Chao, Md, MD | Medical Oncology | Durham, NC | $13,197 | $0 |
| Dr. Niti Goel, Md, MD | Rheumatology | Morrisville, NC | $12,000 | $0 |
| Nashat Gabrail, M.d, M.D | Specialist | Canton, OH | $10,809 | $0 |
| Dr. Kenneth Anderson, Md, MD | Medical Oncology | Boston, MA | $10,750 | $0 |
| Elias Jabbour, M.d, M.D | Hematology & Oncology | Houston, TX | $10,375 | $0 |
| Roy Chemaly, M.d, M.D | Infectious Disease | Houston, TX | $10,073 | $0 |
| Gary Lyman, Md, MD | Medical Oncology | Seattle, WA | $9,384 | $0 |
| Genovefa Papanicolaou, Md, MD | Infectious Disease | New York, NY | $9,173 | $0 |
| Dr. Ali Ataya, M.d, M.D | Critical Care Medicine | Gainesville, FL | $9,131 | $0 |
| Steven Devine, M.d, M.D | Medical Oncology | Columbus, OH | $9,014 | $0 |
| Joshua Brody, M.d, M.D | Hematology & Oncology | New York, NY | $8,510 | $0 |
| Dr. Jonathan Marron, Md, MD | Pediatrics | Boston, MA | $8,000 | $0 |
| Christine Duncan, M.d, M.D | Pediatric Hematology-Oncology | Boston, MA | $7,975 | $0 |
About Partner Therapeutics, Inc.
Partner Therapeutics, Inc. has made $26.1M in payments to 562 healthcare providers, recorded across 1,807 transactions in the CMS Open Payments database. In 2024, the company paid $481,918. The top product by payment volume is LEUKINE ($22.2M).
Payments were distributed across 39 medical specialties. The top specialty by payment amount is Hematology & Oncology ($1.4M to 220 doctors).
Payment categories include: Food & Beverage ($22,637), Consulting ($2.1M), Research ($23.5M), Travel & Lodging ($25,268).
Partner Therapeutics, Inc. is associated with 2 products in the CMS Open Payments database.